Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04692818 · ClinicalTrials.gov registry record · NA
3D Ultrasound Breast Imaging
A NA study of Breast Tumor, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT04692818: Recruiting NA study of Breast Tumor, sponsored by Mayo Clinic.
NCT04692818 is a NA study of Breast Tumor that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 125 participants, below the 1,406-participant average among 6 other Breast Tumor trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04692818, a NA study of Breast Tumor, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to study the efficacy of a new ultrasound imaging method for diagnosis of breast mass.
Primary Outcome
BI-RADS scores will be obtained using 2D B-mode ultrasound images from the GE Logiq E10 clinical scanner, and using 3D B-mode images from the Verasonics scanner. A 7-point BI-RADS scale will be used, with a score of 1, 2, or 3 considered negative and 4a, 4b, 4c, and 5 considered positive.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST GE Logiq E10 clinical ultrasound scanner
- DIAGNOSTIC_TEST Verasonics research scanner
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2021-11-10 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT04692818 shows while recruiting
NCT04692818 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 1,406-participant average among 6 other Breast Tumor trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Breast Tumor appearing as the primary indexed condition, and to 2 interventions - of which GE Logiq E10 clinical ultrasound scanner is the first listed.
NCT04692818 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04692818 about?
NCT04692818 is a clinical study titled "3D Ultrasound Breast Imaging". The purpose of this research is to study the efficacy of a new ultrasound imaging method for diagnosis of breast mass.
What is the current status of trial NCT04692818?
This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2021-11-10. Estimated completion is 2026-12-31.
What conditions does trial NCT04692818 study?
This clinical trial studies the following conditions: Breast Tumor.
What interventions are being tested in trial NCT04692818?
The interventions under investigation include: GE Logiq E10 clinical ultrasound scanner (DIAGNOSTIC_TEST), Verasonics research scanner (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04692818?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04692818 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Radiofrequency Chip for Localization of Non-Palpable Breast Lesions
COMPLETED · NA
-
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
RECRUITING
-
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
RECRUITING · Phase 1
-
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
RECRUITING · Phase 2
-
Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients
ACTIVE NOT RECRUITING · Phase 2
-
Proton Radiation for Stage II/III Breast Cancer
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI